Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: 4 | Mind Blowing Facts

Musk declares ‘war’ on advertisers as X sues ad alliance, companies

In its lawsuit, X said an advertisers alliance conspired to withhold ‘billions of dollars’ in ad revenue from it.

Al Jazeera

Drugstores tinker with new looks as their usual way of doing business faces challenges

America’s drugstores are testing smaller locations and more ways to offer care as more store closings loom

The Independent UK

Do Wall Street Analysts Like CVS Health Stock?

CVS Health has underperformed the broader market over the past year, but Wall Street analysts still maintain a moderately optimistic view of the stock's prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What to Expect From CVS Health's Q2 2024 Earnings Report

CVS Health is all set to announce its second-quarter results next month, and analysts are projecting a double-digit decline in the company’s bottom-line figure.

Barchart

CVS Health CTO tries to smooth over complexity to propel his company's big bet on healthcare

CTO Tilak Mandadi is juggling a complex business with many different units.

Fortune

CVS Stock Plunges as Medicare Advantage Costs Spike

CVS Health came up short of Q1 earnings estimates and slashed its full-year outlook as medical costs surged. Here's what you need to know.

Kiplinger

CVS Health Reports Strong Q4 Results, Projects Growth In 2024

CVS Health's Q4 results show growth potential despite stock volatility. Valuation suggests room for growth. Consider performance relative to peers for inve...

Top News

Read news from The Economist, FT, and more,
with one subscription

30 Most Powerful Women In Business: The Titans Of Industry

Here are the women, who are forging paths and breaking barriers across industries, showcasing exceptional leadership and innovation.

International Business Times

Is CVS Health's Revenue Success Overshadowed By Rising Healthcare Costs?

CVS Health reports strong revenue but slashes full-year profit outlook due to surging medical costs.

International Business Times

CVS Health (CVS) Pre-Earnings Analysis: Buy or Hold?

The largest U.S. drugstore chain, CVS Health (CVS), will release its fourth-quarter results on February 7. The company is expected to report year-over-year growth in revenue and earnings. With the expected rise in medical costs during the fourth quarter, should investors consider buying the stock now? Read on to learn…

StockNews.com

CVS Pharmacy Revamps Loyalty Program

CVS loyalty program members will now have two tiers of 'ExtraCare' benefits to choose from.

Kiplinger

Medicare Advantage Enrollee Numbers Are Rising — Here's Why

Enrollment in Medicare Advantage plans has outpaced expectations, but people should use caution when viewing these plans, expert says.

Kiplinger

Looking back on the challenges CEOs faced in 2023, from war to climate change to the A.I. boom

Looking ahead, 2024 likely will be filled with volatility, uncertainty, complexity, and ambiguity. That’s "VUCA" for you.

Fortune

Major Pharmacies Give Cops Patient Records Without a Warrant, Lawmakers' Investigation Finds

Three major pharmacy chains admitted to encouraging staff to hand prescription records over to law enforcement without a warrant, and without a legal review.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

CVS Health lays out changes to clarify prescription drug pricing that may save some customers money

CVS Health is introducing changes to how its prescription drug pricing model works, and that could lead to some savings for customers starting next year

The Independent UK

Indian manufacturer recalls eyedrops previously cited in FDA warning

The Indian manufacturer of more than a number of eyedrops subject to a U.S. safety warning has officially recalled the products

The Independent UK

Pharmacists prescribe another round of US protests to highlight working conditions

Drugstore employees around the country have started calling in sick to highlight a lack of support from their employers

The Independent UK

CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors

CVS Health is pulling from its drugstore shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Girls deserve better period education, and we can all contribute

Girls are getting their periods earlier than ever. Here’s how menstrual education needs to change.

Fortune

CVS CEO sees changes coming ‘faster than a freight train’ for Medicare. She’s betting billions she can build a new American health care system

CVS is betting billions it can avert the 'Medicare tsunami' and change American health care.

Chicago Sun-Times

Chicagoans looking for new COVID-19 shot face supply issues, insurance hiccups

Some large hospital systems in Chicago don’t have vaccines available yet, despite the doses being approved weeks ago.

Fortune

Fortune's 2023 Most Powerful Women list is here

Execs from Meta, Chanel, CVS Health and more appear on Fortune's Most Powerful Women list.

Kiplinger

CVS Launches Cordavis to Target Biosimilars Market

New CVS unit aims to cut your prescription costs by offering alternatives to branded drugs.

StockNews.com

Walgreens Boots Alliance (WBA), CVS Health (CVS), and Rite Aid (RAD): Buy, Hold or Sell?

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

Capital & Main

Americans With Health Insurance Are Increasingly Putting Off Important Medical Treatments They Can’t Afford

Health insurance CEOs pocket millions while citizens can’t pay the out-of-pocket.

1 … 3 4 5 6

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations